Reason for withdrawal from publication
In 2016, this review was passed from the Cochrane Musculoskeletal Review Group to the Pain, Palliative and Supportive Care (PaPaS) Review Group, due to the scope.
At October 2017, this review has been withdrawn. An update was in progress and was assessed by the Cochrane Funding Arbiter panel, who advised the following:
“Referral ref#239. The Funding Arbiters and Panel received all the information provided in your emails…The problem in this case is … that fact that the lead author, Dr Nurcan Üçeyler, has received financial support in the last 3 years from commercial sponsors or sources who have a real or potential financial interest in the findings of the review. The Lead Author of a review cannot have any conflicts whatsoever… The original version of the review was not compliant with the policy and neither is this update. Therefore the Funding Panel has determined that the update cannot be published and that the original review should be withdrawn.”
The editorial group responsible for this previously published document have withdrawn it from publication.
What's new
| Date | Event | Description |
|---|---|---|
| 9 October 2017 | Amended | This review has been withdrawn. See Published notes. |
History
Review first published: Issue 10, 2013
| Date | Event | Description |
|---|---|---|
| 23 October 2012 | Amended | The protocol 'Antidepressants and centrally active agents for fibromyalgia syndrome' published in 2006 (Nishishinya 2006) has been split into several systematic reviews that will be/have been published as: ‐ Anticonvulsants for fibromyalgia ‐ Monoamine oxidase inhibitors (MAOIs) for fibromyalgia syndrome ‐ Non‐steroidal anti‐inflammatory drugs (NSAIDs), analgesics and opioid agents for fibromyalgia ‐ Sedatives and hypnotic agents for fibromyalgia ‐ Selective serotonin reuptake inhibitors (SSRIs) for fibromyalgia ‐ Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome ‐ Tricyclic agents for fibromyalgia |
Withdrawn from publication for reasons stated in the review